SCHEMBL4430914

SCHEMBL4430914

CC1Cc2cc(OC(=O)O)sc2CN1C

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
AKR1C3 P42330 1/20 0.30
ABCB11 O95342 1/20 0.30
CHRM2 P08172 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
AR P10275 1/20 0.30
OPRM1 P35372 1/20 0.30
P2RY12 Q9H244 1/20 0.30
RXRA P19793 1/20 0.30
RXRB P28702 1/20 0.30
RXRG P48443 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436567 0.86 ALDH1A1 (0.33) ALDH1A1ABCB11CHRM2ADORA3AR
SCHEMBL3314687 0.78 ALDH1A1 (0.45) ALDH1A1
SCHEMBL3309036 0.75 NPC1 (0.49) ALDH1A1
SCHEMBL4433993 0.74 PARP1 (0.41) ALDH1A1
SCHEMBL16712260 0.74 ALDH1A1 (0.53) ALDH1A1
SCHEMBL16712256 0.71 ALDH1A1 (0.41) ALDH1A1
SCHEMBL4440903 0.71 PARP1 (0.41) ALDH1A1ABCB11CHRM2ADORA3AR
SCHEMBL4433208 0.71 ABCB11 (0.36) ALDH1A1ABCB11CHRM2ADORA3AR
SCHEMBL4428249 0.70 OPRM1 (0.41) AKR1C3OPRM1
SCHEMBL4433487 0.70 OPRM1 (0.41) AKR1C3OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132193-B1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS BOEHRINGER INGELHEIM INT (DE) 2012-10-24 EP disclosed
EP-2132193-A1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS Boehringer Ingelheim International GmbH (DE) 2009-12-16 EP disclosed
WO-2008116881-A1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-10-02 WO disclosed